AU Stock MarketDetailed Quotes

NEU Neuren Pharmaceuticals Ltd

Watchlist
  • 13.190
  • +0.230+1.77%
20min DelayMarket Closed May 16 16:00 AET
1.68BMarket Cap12.15P/E (Static)

Neuren Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neuren Pharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/H2-- / 36.500M--
--2025/H1-- / 27.500M--
Feb 28, 20252024/H2188.916M / 108.600M--
--2024/H124.327M / 24.100M--
Feb 29, 20242023/H2168.999M / 169.600M--
DatePeriodRevenue/EstimateEarnings Call
--2025/H2-- / 36.500M--
--2025/H1-- / 27.500M--
Feb 28, 20252024/H2188.916M / 108.600M--
--2024/H124.327M / 24.100M--
Feb 29, 20242023/H2168.999M / 169.600M--

Unlock Free Earnings Estimates

Neuren Pharmaceuticals Ltd Earnings Reports

  • Neuren Pharmaceuticals Ltd: DAYBUE Q1 2025 net sales US$84.6m up 11% from Q1 2024

    May 7 19:02 ET

  • Neuren Pharmaceuticals Ltd: 2024 Annual Report to shareholders

    Apr 2 16:51 ET

  • Neuren Pharmaceuticals Ltd: 2024 Full Year Results webinar

    Feb 27 20:10 ET

  • Neuren Pharmaceuticals Ltd: 2024 results - A$166m comprehensive income for shareholders

    Feb 27 17:35 ET

    • Read more

    Market Insights

    ASX High Dividend ASX High Dividend
    No. Symbol Price
    BHP Group Ltd
    BHP
    39.720
    Fortescue Ltd
    FMG
    17.000
    National Australia Bank Ltd
    NAB
    37.010
    4
    Rio Tinto Ltd
    RIO
    121.050
    5
    Telstra Group Ltd
    TLS
    4.530
    Log In for the Full List
    Unlock Now